Default company panoramic image

Vital Art and Science, LLC

The mVT™ Service detects early visual function changes related to retinal diseases, which can lead to sooner treatment and better patient outcomes.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location United States
  • Currency USD
  • Founded June 2006
  • Employees 3
  • Website

Company Summary

Vital Art and Science, LLC has developed the first FDA cleared smartphone-based home vision function monitor for those afflicted with degenerative eye diseases such as diabetic retinopathy (DR) and Age Related Macular Degeneration (AMD). These afflict over 25M people in both the US and Europe today. The mVT™ Service is by prescription only and provides an easy and accurate way for patients to test their vision at home .


  • Default avatar
    Mike Bartlett

    Mike has over 30 years of experience in the electronics industry, including 5 years as Vice President of Texas Instrument during which time he was responsible for defining, developing and bringing to market hundreds of new electronic products.

  • Default avatar
    Yi-Zhong Wang
    Chief Science Officer

    Yi-Zhong Wang, Ph.D., is a research scientist at Retina Foundation of Southwest and has over 20 years of research experience and skills in visual psychophysics, visual optics, computational modeling, computer programming, and development of new visual function tests. He has extensive experience working with seniors and patients with macular degeneration, diabetic retinopathy and Amblyopia.


  • Default avatar
    Tod Mongan, Mongan Law
    Default avatar
    Montgomery Coscia Greilich LLP

Previous Investors

  • Default avatar
    National Eye Institute Phase I and Phase II SBIR Grants
    Default avatar
    Texas Emerging Technology Fund